These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 37931732)

  • 1. Low-density lipoprotein triglyceride predicts outcomes in patients with chronic coronary syndrome following percutaneous coronary intervention according to inflammatory status.
    Zhang HW; Guo YL; Wu NQ; Zhu CG; Dong Q; Sun J; Dou KF; Li JJ
    Clin Chim Acta; 2023 Nov; 551():117631. PubMed ID: 37931732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Associations between postprocedural D-dimer, hs-CRP, LDL-C levels and prognosis of acute myocardial infarction patients treated by percutaneous coronary intervention].
    Chen RZ; Liu C; Zhou P; Tan Y; Sheng ZX; Li JN; Zhou JY; Wu Y; Yang YM; Song L; Zhao HJ; Yan HB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 May; 48(5):359-366. PubMed ID: 32450651
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidized low-density lipoprotein and C-reactive protein have combined utility for better predicting prognosis after acute coronary syndrome.
    Zhang YC; Tang Y; Chen Y; Huang XH; Zhang M; Chen J; Sun YG; Li YG
    Cell Biochem Biophys; 2014 Mar; 68(2):379-85. PubMed ID: 23943054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triglyceride to High-Density Lipoprotein Cholesterol Ratio and Cardiovascular Events in Diabetics With Coronary Artery Disease.
    Yang SH; Du Y; Li XL; Zhang Y; Li S; Xu RX; Zhu CG; Guo YL; Wu NQ; Qing P; Gao Y; Cui CJ; Dong Q; Sun J; Li JJ
    Am J Med Sci; 2017 Aug; 354(2):117-124. PubMed ID: 28864368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of high-sensitivity C-reactive protein during follow-up on long-term adverse clinical outcomes in patients with coronary artery disease treated with percutaneous coronary intervention.
    Shitara J; Ogita M; Wada H; Tsuboi S; Endo H; Doi S; Konishi H; Naito R; Dohi T; Kasai T; Okazaki S; Isoda K; Suwa S; Miyauchi K; Daida H
    J Cardiol; 2019 Jan; 73(1):45-50. PubMed ID: 30001869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy.
    Ndrepepa G; Braun S; Tada T; Guerra E; Schunkert H; Laugwitz KL; Kastrati A
    Cardiovasc Revasc Med; 2014 Apr; 15(3):131-6. PubMed ID: 24630704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein predicts long-term mortality independently of low-density lipoprotein cholesterol in patients undergoing percutaneous coronary intervention.
    Razzouk L; Muntner P; Bansilal S; Kini AS; Aneja A; Mozes J; Ivan O; Jakkula M; Sharma S; Farkouh ME
    Am Heart J; 2009 Aug; 158(2):277-83. PubMed ID: 19619706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.
    Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
    Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of eosinophil percentage and high-sensitivity C-reactive protein predicts in-hospital major adverse cardiac events in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
    Ye L; Bai HM; Jiang D; He B; Wen XS; Ge P; Zhang DY
    J Clin Lab Anal; 2020 Sep; 34(9):e23367. PubMed ID: 32441412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preprocedural High-Sensitivity C-Reactive Protein Predicts Long-Term Outcome of Percutaneous Coronary Intervention.
    Wada H; Dohi T; Miyauchi K; Shitara J; Endo H; Doi S; Naito R; Konishi H; Tsuboi S; Ogita M; Kasai T; Hassan A; Okazaki S; Isoda K; Shimada K; Suwa S; Daida H
    Circ J; 2016 Dec; 81(1):90-95. PubMed ID: 27867158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting high-sensitivity C-reactive protein levels in acute coronary syndrome patients undergoing contemporary lipid-lowering therapy: a sub-analysis of the HIJ-PROPER trial.
    Kawada-Watanabe E; Yamaguchi J; Sekiguchi H; Arashi H; Ogawa H; Hagiwara N
    J Cardiol; 2020 May; 75(5):500-506. PubMed ID: 31699568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of high-sensitivity C-reactive protein among chronic kidney disease patients undergoing percutaneous coronary intervention.
    Jones D; Spirito A; Sartori S; Smith KF; Pivato CA; Chiarito M; Cao D; Nicolas J; Beerkens F; Edens M; Pileggi B; Sen A; Zhang Z; Vogel B; Sweeny J; Baber U; Dangas G; Sharma SK; Kini A; Mehran R
    J Cardiol; 2023 Sep; 82(3):179-185. PubMed ID: 37187289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Remnant Lipoprotein Cholesterol and Oxidized Low density Lipoprotein Associated with Low-grade Inflammation in Coronary Heart Disease Subjects of Young South Indian Population.
    Jaishankar T; Shivasekar M; Vinodhini VM
    J Assoc Physicians India; 2022 Jun; 70(6):11-12. PubMed ID: 35702834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of Ezetimibe and Simvastatin Combination Therapy on percutaneous coronary intervention patients.
    Lin H; Zhang YM
    Int J Cardiol; 2017 Sep; 242():1-3. PubMed ID: 28550977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of diurnal fasting during Ramadan on the lipid profile, hs-CRP, and serum leptin in stable cardiac patients.
    Khafaji HA; Bener A; Osman M; Al Merri A; Al Suwaidi J
    Vasc Health Risk Manag; 2012; 8():7-14. PubMed ID: 22272070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher serum triglyceride can predict recurrent coronary revascularization events in patients undergoing percutaneous coronary intervention with baseline LDL-C <55 mg/dL.
    Fan X; Wang X; She J; Niu X; Luo Y; Xi W; Zheng T; Wu Y
    J Investig Med; 2023 Jan; 71(1):47-52. PubMed ID: 36655323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between very low concentrations of low density lipoprotein cholesterol, high sensitivity C-reactive protein, and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study.
    Penson PE; Long DL; Howard G; Toth PP; Muntner P; Howard VJ; Safford MM; Jones SR; Martin SS; Mazidi M; Catapano AL; Banach M
    Eur Heart J; 2018 Oct; 39(40):3641-3653. PubMed ID: 30165636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-Density Lipoprotein Cholesterol Concentrations and Association of High-Sensitivity C-Reactive Protein Concentrations With Incident Coronary Heart Disease in the Multi-Ethnic Study of Atherosclerosis.
    Lin GM; Liu K; Colangelo LA; Lakoski SG; Tracy RP; Greenland P
    Am J Epidemiol; 2016 Jan; 183(1):46-52. PubMed ID: 26597828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic inflammation and metabolic syndrome in cardiac allograft vasculopathy.
    Raichlin ER; McConnell JP; Lerman A; Kremers WK; Edwards BS; Kushwaha SS; Clavell AL; Rodeheffer RJ; Frantz RP
    J Heart Lung Transplant; 2007 Aug; 26(8):826-33. PubMed ID: 17692787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.